(Q39125415)

9 September 2017

title

The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma (English)

1 reference

9 September 2017

1 reference

He Ren

1

1 reference

9 September 2017

Tiansuo Zhao

2

1 reference

9 September 2017

Junwei Sun

3

1 reference

9 September 2017

Xiuchao Wang

4

1 reference

9 September 2017

Jingcheng Liu

5

1 reference

9 September 2017

Song Gao

6

1 reference

9 September 2017

Ming Yu

7

1 reference

9 September 2017

Jihui Hao

8

1 reference

9 September 2017

publication date

1 November 2013

1 reference

Journal of Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

114

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

2603-2611

1 reference

Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism

9 September 2017

cites work

1 reference

Brick by brick: metabolism and tumor cell growth

21 January 2018

1 reference

Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.

21 January 2018

1 reference

Inflammation and the development of pancreatic cancer

21 January 2018

1 reference

Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer

21 January 2018

1 reference

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

21 January 2018

1 reference

Otto Warburg's contributions to current concepts of cancer metabolism

21 January 2018

1 reference

Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma

21 January 2018

1 reference

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

Hypoxia: a key regulator of angiogenesis in cancer

21 January 2018

1 reference

Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting

21 January 2018

1 reference

The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology

21 January 2018

1 reference

Targeting of cancer energy metabolism.

21 January 2018

1 reference

Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia

21 January 2018

1 reference

Regulation of metabolism by hypoxia-inducible factor 1.

21 January 2018

1 reference

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells

21 January 2018

1 reference

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

21 January 2018

1 reference

Downregulation of G protein-coupled receptors

21 January 2018

1 reference

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

On the Origin of Cancer Cells

21 January 2018

1 reference

Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling

21 January 2018

1 reference

High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24608

1 reference

9 September 2017

1 reference